The latest in Sanofi-Aventis SA

WHO suspends vaccine by Sanofi-Aventis subsidiary

2010-03-17T10:30:22Z

<div><p>The U.N. health agency said Wednesday it has suspended its approval of a vaccine against tetanus and four other diseases produced by Sanofi-Aventis SA subsidiary because of a white substance forming inside some vials.</p><p>The World Health Organization and th...

Merck, Sanofi combining animal medicine businesses

2010-03-09T13:30:10Z

<div id="subtitle">Merck, Frontline maker Sanofi-Aventis uniting animal medicine businesses into world's largest</div><div><p>Two of the world's biggest pharmaceutical companies said Tuesday they are uniting their animal health businesses in a deal to become the top dog in the veterinary industry.</p><p>Merck & Co. and France's Sanofi-Aventis S...

Sanofi, Merck link up to create animal health giant

2010-03-09T11:19:19Z

<div><p>French pharmaceutical giant Sanofi-Aventis and US group Merck announced on Tuesday they would join forces to create the world's biggest animal health company.</p><p>The companies will own an equal share in the joint venture, which will combine Sanofi-Aventis's Merial unit with Merck's Intervet/Sanofi-Aventis joining animal medicine businesses into world's largest</div><div><p>PET MEDS: Two top pharmaceutical companies, Merck & Co. and Sanofi-Aventis SA, are uniting their animal health businesses in what would be the world's largest veterinary medicine company.</p><p>GOOD FIT: Sanofi's Merial makes some very popular dog and cat products...

Sanofi drug shows promise against prostate cancer

2010-03-03T15:16:06Z

<div id="subtitle">Experimental drug modestly boosts survival in men with advanced prostate cancer, study finds</div><div><p>For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.</p><p>The benefit was modest — an extra 10 weeks — but cancer specialists were excited because no chemotherapy un...

European regulator recommends fifth swine flu vaccine

2010-02-22T08:13:50Z

&lt;div&gt;&lt;p&gt;The European Medicines Agency (EMEA) on Friday recommended a swine flu pandemic vaccine produced by French pharmaceutical group Sanofi-Aventis for European use.&lt;/p&gt;&lt;p&gt;"The European Medicines Agency's Sanofi-Aventis says European Union committee recommends approval for Humenza swine flu shot&lt;/div&gt;&lt;div&gt;&lt;p&gt;A European Union committee recommended that Sanofi-Aventis' swine flu vaccine Humenza be approved for sale, the French drugmaker said Friday.&lt;/p&am...

Sanofi says vaccines to help lift 2010 earnings

2010-02-22T10:24:24Z

<div><p>PARIS (Reuters) - French drugmaker Sanofi-Aventis beat forecasts for fourth-quarter profit and expects earnings to rise 2 to 5 percent this year as growth areas such as vaccines offset stronger competition from generic rivals.</p><p>But Sanofi's forecast for business earnings per share (EPS) at constant...

Sanofi-Aventis Q4 profit up on swine flu vaccines

2010-02-22T10:24:53Z

<div id="subtitle">Sanofi-Aventis 4th quarter net profit up 10 pct as flu vaccine demand drives sales</div><div><p>Sanofi-Aventis reported a 10 percent increase in fourth quarter net profit Wednesday as strong sales of its swine flu vaccine drove full year earnings above expectations.</p><p>France's large...

Sanofi-Aventis completes tender offer for Chattem

2010-02-22T10:37:30Z

<div id="subtitle">Sanofi-Aventis says it completed $1.9 billion tender offer for Gold Bond maker Chattem</div><div><p>French drugmaker Sanofi-Aventis said Tuesday it completed its tender offer for shares of Chattem Inc., which makes Gold...

FTC clears Sanofi-Aventis purchase of Chattem

2010-02-22T14:44:19Z

<div id="subtitle">Sanofi-Aventis says review of $1.9B deal for Gold Bond maker is over, paving the way for sale</div><div><p>Regulators have cleared Sanofi-Aventis' $1.9 billion purchase of Gold Bond skin products maker Chattem Inc., the...

"Silent pandemic" will force drug price rethink

2010-02-22T17:40:51Z

<div><p>LONDON (Reuters) - A "silent pandemic" of chronic disease is creeping up on poor countries and will force pharmaceutical firms to take a more tiered approach to pricing some of their most lucrative medicines.</p><p>Drugs for diseases which were previously dominant only in the rich, well-fed world, such as diabetes, heart disease and cancer, are increasingly in demand ...

U.S. scales back H1N1 vaccine, cuts CSL order in half

2010-02-22T22:20:37Z

<div><p>SYDNEY (Reuters) - The United States has scaled back its supply of H1N1 flu vaccine, cutting its order with Australian firm CSL Ltd in half, the company said on Monday.</p><p>The U.S. move follows other nations which have also cut back swine flu vaccines as health authorities around the world grapple with overs...

Vical says gov't clears melanoma vaccine for dogs

2010-02-22T22:14:53Z

<div id="subtitle">Vical says US approves Oncept dog vaccine, which will be marketed by Sanofi-Aventis</div><div><p>Drug developer Vical Inc. said Monday the Agriculture Department...

Sanofi-Aventis appoints new VP, consumer health

2010-02-22T23:30:36Z

<div id="subtitle">Sanofi-Aventis names Hans Regenauer VP of consumer health care in Europe, global development</div><div><p>Drug developer Sanofi-Aventis said Friday it named Hans Regenauer vice president of consumer health care in Europe and of global development.<...

US freezes assets of Frenchmen in insider trading case

2010-02-23T11:54:19Z

<div><p>US authorities said Wednesday they had obtained an emergency asset freeze against two French men accused of insider trading in an apparent attempt to illegally profit from a US company takeover.</p><p>The Securities and Exchange Commission said it won a court order on...

Sanofi-Aventis to buy Gold Bond maker Chattem

2010-02-23T13:07:10Z

<div id="subtitle">Sanofi-Aventis to buy health-care company Chattem for $1.9 billion, entree into US OTC market</div><div><p>French drugmaker Sanofi-Aventis SA said Monday it plans to buy U.S. health-care company Chattem Inc., maker of over-the-counter mainstays ...

Sanofi Chattem

2009-12-21T09:45:06Z

FILE - In this May 12, 2009 file photo, Sanofi CEO, Chris Viehbacher, delivers his speech during the launch of Sanofi Pasteur's new plant, Sanofi's 11th vaccine production plant in the world. French drugmaker Sanofi-Aventis SA said Monday, Dec. 21, 2009, it plans to buy Reuters) - Sanofi-Aventis &lt;SASY.PA&gt; is to buy U.S. consumer healthcare group Chattem Inc &lt;CHTT.O&gt; for around $1.9 billion, in a deal which will give the French drugmaker over-the-counter presence in the huge Sanofi-Aventis said Monday it was to acquire Chattem of the United States for for 1.9 billion dollars, creating the world's fifth largest consumer health care company.</p><p>"The acquisition of Chattem will be a significant mile...